Sign In
Buy GTHX
$7.15
+0 (+0%)
At Close: Dec 16, 2024
G1 Therapeutics Inc (NASDAQ:GTHX) Receives Consensus Rating of "Buy" from Analysts
08:20am, Friday, 17'th Apr 2020
Shares of G1 Therapeutics Inc (NASDAQ:GTHX) have earned a consensus rating of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One research analyst
Zacks Investment Research Upgrades G1 Therapeutics (NASDAQ:GTHX) to Buy
06:04am, Friday, 17'th Apr 2020
G1 Therapeutics (NASDAQ:GTHX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday, Zacks.com reports. The firm presently has a $14.0
G1 Therapeutics (NASDAQ:GTHX) Rating Increased to Sell at BidaskClub
07:44am, Wednesday, 15'th Apr 2020
G1 Therapeutics (NASDAQ:GTHX) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Wednesday, BidAskClub reports. Several other eq
Cubist Systematic Strategies LLC Acquires Shares of 11,769 G1 Therapeutics Inc (NASDAQ:GTHX)
09:29am, Tuesday, 14'th Apr 2020
Cubist Systematic Strategies LLC acquired a new position in shares of G1 Therapeutics Inc (NASDAQ:GTHX) during the fourth quarter, according to its most recent disclosure with the Securities and Excha
Goldman Sachs Group Inc. Trims Holdings in G1 Therapeutics Inc (NASDAQ:GTHX)
10:02am, Friday, 10'th Apr 2020
Goldman Sachs Group Inc. decreased its holdings in G1 Therapeutics Inc (NASDAQ:GTHX) by 32.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Ex
G1 Therapeutics (NASDAQ:GTHX) Trading Down 5.3%
10:04am, Wednesday, 08'th Apr 2020
G1 Therapeutics Inc (NASDAQ:GTHX) shares fell 5.3% during trading on Tuesday . The stock traded as low as $10.55 and last traded at $10.61, 635,212 shares were traded during mid-day trading. An increa
G1 Therapeutics (NASDAQ:GTHX) Upgraded at Zacks Investment Research
05:18am, Wednesday, 08'th Apr 2020
G1 Therapeutics (NASDAQ:GTHX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday, Zacks.com reports. The brokerage curr
G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020
11:00am, Tuesday, 07'th Apr 2020
RESEARCH TRIANGLE PARK, N.C., April 07, 2020 -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark.
Credit Suisse AG Grows Holdings in G1 Therapeutics Inc (NASDAQ:GTHX)
08:24am, Saturday, 04'th Apr 2020
Credit Suisse AG lifted its position in shares of G1 Therapeutics Inc (NASDAQ:GTHX) by 12.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission.
G1 Therapeutics (NASDAQ:GTHX) Rating Lowered to Strong Sell at BidaskClub
07:24am, Friday, 03'rd Apr 2020
G1 Therapeutics (NASDAQ:GTHX) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Friday, BidAskClub reports. Several
G1 Therapeutics (NASDAQ:GTHX) Trading 5.4% Higher
07:10am, Tuesday, 31'st Mar 2020
G1 Therapeutics Inc (NASDAQ:GTHX) rose 5.4% during mid-day trading on Monday . The stock traded as high as $11.96 and last traded at $11.95, approximately 240,738 shares traded hands during mid-day tr
NextCure appoints Garry Nicholson to board of directors NXTC;GTHX
11:52am, Monday, 30'th Mar 2020
NextCure appoints Garry Nicholson to board of directors NXTC GTHX
NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors
11:05am, Monday, 30'th Mar 2020
NextCure, Inc. (NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today
G1 Therapeutics (NASDAQ:GTHX) Trading 5.8% Higher
07:02am, Thursday, 26'th Mar 2020
G1 Therapeutics Inc (NASDAQ:GTHX) traded up 5.8% on Tuesday . The stock traded as high as $11.51 and last traded at $11.29, 337,984 shares traded hands during trading. An increase of 10% from the aver
Bank of Montreal Can Grows Holdings in G1 Therapeutics Inc (NASDAQ:GTHX)
10:06am, Wednesday, 25'th Mar 2020
Bank of Montreal Can lifted its position in shares of G1 Therapeutics Inc (NASDAQ:GTHX) by 43.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exch
